Suzhou Kintor Pharmaceuticals studies lead c-Myc/MAX protein-protein interaction inhibitor July 7, 2020
CH-7233163: an EGFR inhibitor active against osimertinib-resistant EGFR-T790M/C797S mutations July 2, 2020